A prospective cohort study was undertaken to describe the natural history of the cubital fossa peripherally inserted central catheter (PICC), determine which factors influenced the hazard of complication and develop a standard methodology for evaluation of a PICC service. A total of 4349 patient days of PICC observation were analysed using survival analysis techniques. The median time to PICC removal for a complication was 60 days. The most common complications were phlebitis, malposition and tip migration. Complications usually occurred during the first week. There was only one episode of line-related sepsis. Size 3 French gauge catheters had a complication rate of 7.3 per 1000 line days compared to 14.2 for 4 French catheters (hazard rate 1.26 90% CI 1.02 to 1.55). PICCs requiring two or more attempts at insertion were more likely to develop complications than those inserted at the first attempt: 20 per 1000 line days vs 10.5 but the confidence intervals were wide (hazard rate 1.91, 90% CI 0.90 to 4.05). Operator (amongst the four experienced operators who inserted all PICCs), arm of placement, or medial or lateral placement in the cubital fossa did not influence PICC survival.
The peripherally inserted central catheter (PICC) has become the standard of care for intermediate and long-term intravenous therapy in many general wards and ambulatory and community based treatment programs. Despite the widespread use of PICCs there is no uniformly accepted means of evaluating the safety and efficacy of the PICC itself or of comparing PICC using services.
The investigators aimed to describe the natural history of a cubital fossa PICC after insertion into a patient and to determine whether any factors assessable prior to insertion have an effect on that natural history. We were particularly interested in the effect of differences between operators, left or right sided PICC placement, the location of the PICC within the cubital fossa, the size of the PICC, the difficulty of insertion as assessed by the number of attempts required and the location of the catheter tip (subclavian vs more central) on the future development of line related complications. We also wished to produce a standard methodology for evaluation of a PICC management service that would enable assessment of new interventions and changes in equipment, operators or technique. This methodology needs to take into account variations in duration of therapy and allow for the fact that most PICCs are removed when therapy is completed, before a complication develops.
The investigators therefore conducted a longitudinal study incorporating survival analysis techniques to follow all patients referred to our PICC management service.
METHODS

PICC Management Service
The investigators are based at a 650 bed university teaching hospital serving a provincial city in New South Wales, Australia. The PICC management service is part of the Immunology and Infectious Diseases Unit and inserts the majority of PICCs for the general wards (i.e. outside of critical care areas). Some of these patients are enrolled on the unit's ambulatory intravenous therapy program and the rest remain under the care of their referring team. The service inserts exclusively cubital fossa PICCs and during the study period all lines were inserted by one of four registered nurses experienced in PICC insertion. The only criteria for acceptance by the PICC management service were that the nurse considered that PICC insertion in the cubital fossa was technically feasible and clinically appropriate.
PICC Insertion
Immediately prior to PICC insertion, the skin was prepared with 0.5% chlorhexidine in 70% alcohol which was allowed at least two minutes to act prior to any skin puncture. Local anaesthetic (ligocaine 1%) was infiltrated into the site of skin puncture using a 25 gauge needle. The choice of 3 or 4 French gauge catheter was left up to the operator. All study subjects received the same brand of catheter (Groshong, Bard Access Systems, Salt Lake City, Utah, U.S.A.) although this was not the original plan. A clear adhesive dressing was applied and changed weekly unless there was blood or fluid at the entry site in which case the dressing was changed daily. All lines were secured with a "StatLock™" catheter securement device (Venetec International, Inc., San Diego, CA, U.S.A.). No sutures we used.
Data Recorded at PICC Insertion
At the time of attempted insertion the following information was recorded: Operator (person who inserted the PICC), side of PICC insertion, location in cubital fossa of PICC entry (medial or lateral), and attempt number. All patients had chest radiographs performed and all available post insertion films were reviewed by three of us (RS, ML, AP) without knowledge of the eventual fate of the PICC. Catheter tip position was classified according to standard anatomical landmarks as being either central (superior vena cava (SVC), or brachiocephalic vein) or subclavian. The following information was also recorded: brand and gauge of catheter, ward area where procedure was performed, skin preparation, use of local anaesthetic or premedication and time and date of insertion.
Patient Follow-Up
Following a successful insertion, a member of the PICC management team reviewed each patient within 48 hours and thereafter regularly during the week after insertion. A notation was made in the patient's medical record requesting that the treating team contact the PICC management service by pager at any time should a problem arise. Any patient in whom a problem was detected at the follow-up visit or who had a problem reported by the treating team was followed by the PICC management service who provide advice and any intervention necessary to solve the problem. The patient was followed until resolution of the problem or removal of the PICC. The medical records of all patients were reviewed to capture any missing PICC removal dates or complications. Those patients enrolled on the ambulatory intravenous therapy program were followed on a daily basis, either being sighted by a team member or contacted by telephone until removal of the PICC.
Complications
All complications were recorded on the data collection form. These complications were either phlebitis, blockage, leakage, breakage, dislodgement or malposition of catheter.
PICC Removal
The reason for PICC removal was recorded as: no longer required, blocked, accidentally removed, damaged, thrombosis, phlebitis, malposition, pain, suspected systemic infection/sepsis, local infection, leakage or unsuccessful insertion.
Patient Consent and Ethical Approval
Patients were informed verbally and in writing, as part of admission documentation, that their results may be used anonymously for education and research. Department policy is that observational studies on routinely collected clinical information is classed as "medical audit" and not submitted for formal ethical review board (Research Ethics Committee) review.
Analysis
The primary endpoint was PICC removal due to a complication. PICC survival time was calculated from the day of insertion until the line was removed or until the last recorded date that the line was functioning. The survival time was censored at the date of removal if therapy had been completed and the line was no longer required. Survival times were also censored at the last date that they were recorded as functioning without complication if the patient was lost to follow-up or died of their underlying disease with a functioning PICC in situ. For the purpose of the analysis all other survival times were scored as failures regardless of the reason for PICC removal. Life-table estimates were calculated according to the method of Kaplan and Meier 1 . The log rank test was used for simple comparisons. The Cox model was used to adjust for prognostic factors and to calculate hazard ratios (HR) and 90% confidence intervals for the variables of interest and as a result the hazard ratio is not the quotient of the incidence rates 2,3 . All reported P values are two-sided. Not all chest radiographs were available for review, making the data incomplete; therefore a separate analysis was performed to test the effect of this factor on PICC survival.
RESULTS
Between 2 February 1997 and 27 September 1999, 231 attempted PICC insertions resulted in 209 successfully inserted PICCs in 174 patients. These comprised 148 patients with one line, 20 with two, 4 with three, 1 with four and 1 with five lines successfully inserted and functioning during the study period. Ninety-two of the patients were enrolled on the Immunology and Infectious Disease Unit's ambulatory intravenous therapy program. Patient age ranged from nine to 88 years (mean 53.7 SD 21.1). Seven patients were aged below 18 years. Attempts at PICC insertion were made for 90 females and 141 males, resulting respectively in 79 and 130 functioning lines. Six patients were transferred to other institutions with functioning PICCs and the exact removal date could not be obtained. Three patients died of their underlying disease with functioning PICC lines in situ. Despite diligence by the PICC management service, 23 patients had their PICCs removed without clear documentation of the reason.
The study captured 4349 patient days of PICC observation. The median time to PICC removal for a complication was 60 days (Figure 1 ). The median PICC dwell time (i.e. time in situ) was 23.4 days (range: 4 hours to 224 days). Reasons for PICC removal and their frequency are shown in Table 1 . The most common complication resulting in line removal was blockage followed by malposition. There was only one episode of line-related infection producing an overall infection rate of less than 0.230 infections per 1000 line days. At the end of the first week of therapy, the survivor function was 0.876 (90% CI 0.829 to 0.911) which only decreased to 0.755 (90% CI 0.691 to 0.807) at the end of the median dwell time. That is, most complications occurred within the first week and PICCs that survived that week were very likely to last until the end of treatment (Figure 1) .
Catheters of 4 French gauge size developed complications requiring removal at a rate of 14.2 per 1000 line days vs 7.3 per 1000 line days for 3 French gauge PICCs (HR 1.26, 90% confidence interval for HR 1.02 to 1.55, P=0.062). The survival curves comparing the two catheter sizes were clearly divergent ( Figure 2 ). PICC survival did not differ between the four nurse inserters (log rank value 5.09, P=0.166).
Dividing the patients into age quartiles at less than 35 years, 35 to 60 years, 60 to 73 years and greater than 73 years did not influence the results (log rank value 2.13, P=0.546). Side of insertion did not predict failure: HR for left vs right was 0.684 (90% CI 0.42 to 1.12). Location in the cubital fossa did not predict failure: HR for medial vs lateral was 1.12 (90% CI 0.51 to 2.49). Only 37 catheter tips were not located in the superior vena cava and all of these were medially located (i.e. close to the SVC). Their outcome did not differ from the 76 patients with more centrally placed catheter tips whose chest radiographs were available for review: HR 1.35 (90% CI 0.71 to 2.57).
Thirteen patients required two attempts at insertion, one required three and one five attempts, the remainder were inserted at the first attempt. The incidence of a complication requiring PICC removal was 20 per 1000 line days for the second or later attempt compared to 10.5 per 1000 line days for those successful on the first attempt. However, the small numbers of patients requiring multiple attempts produced a wide confidence interval (HR 1.91 90% CI 0.90 to 4.05). The survival curve comparing single and multiple attempts suggests decreased early line survival in those requiring more than one attempt at insertion.
DISCUSSION
In our institution, a cubital fossa PICC provides a safe effective means of administering intravenous therapy. A PICC can be expected to last two months without complication. Complications that do occur are most likely in the first week. A wide variety of complications occurred. The most common complication resulting in line removal was phlebitis. Linerelated sepsis was a very rare event. This means that the PICC compares favourably with any other means of venous access 4 and is the method of choice for most intermediate or longer term intravenous therapy.
The results of our four experienced PICC inserters were very consistent, indicating the benefit of having PICCs inserted by skilled operators.
Our study confirms the increased complication rate associated with larger catheter sizes [4] [5] [6] . We conclude that a 3 French catheter is the most appropriate size for adult patients.
Side of insertion and location of the insertion site in the cubital fossa did not influence the complication rate. Therefore the most suitable vein can be chosen for PICC insertion irrespective of its location in the cubital fossa. Other investigators have convincingly demonstrated that subclavian placement of the catheter tip was associated with a higher complication rate [7] [8] [9] . Although we did not find this to be the case we only had a small number of lines in the subclavian vein and those were medially placed, probably accounting for the lack of effect. Our data suggest that lines requiring more than one attempt at insertion are more likely to have an early complication. Larger numbers are needed to determine whether this trend is real or spurious. If a vein is traumatized by an earlier attempt at catheter insertion, it may be more likely to develop thrombophlebitis following a second or later PICC insertion.
Survival analysis allowed valid comparisons to be made between lines that had been in situ for varying lengths of time. This technique allows us to make use of large numbers of patient days of observation from patients whose PICCs were removed without complication (i.e. the true PICC survival was unknown) in our statistical analysis. Survival curves provided a visual representation of our data from which it was clear that most complications occurred in the first week after PICC insertion. This is a definite advantage over methods using incidence density or cumulative incidence [10] [11] [12] as these incorrectly assume a constant hazard over the period of observation.
We have adopted these methods for assessment of all interventions and for quality assurance purposes. We propose that they should be the standard methods for follow-up and reporting studies involving PICCs.
